Clinical Trial

The Effect of Preoperative Maxigesic® on Intraoperative Remifentanil Requirement

Recruiting
View on ClinicalTrials.gov →
Summary
Maxigesic is combined intravenous analgesic of ibuprofen and acetaminphen. The purpose of this study is investigate weather preoperative Maxigesic administration can reduce intraoperative remifentanil requirement.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-08-23.
Status change: Not Yet Recruiting → Recruiting 2025-09-30
Trial Details
NCT Number NCT06015711
Lead Sponsor Ajou University School of Medicine
Conditions Opioid Use
Enrollment 96 participants
Start Date 2023-08-30
Primary Completion 2026-08-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-10-03